z-logo
open-access-imgOpen Access
Comparing Plasma Phospho Tau, Total Tau, and Phospho Tau–Total Tau Ratio as Acute and Chronic Traumatic Brain Injury Biomarkers
Author(s) -
Richard Rubenstein,
Binggong Chang,
John K. Yue,
Allen W. Chiu,
Ethan A. Winkler,
Ava M. Puccio,
Ramon DiazArrastia,
Esther L. Yuh,
Pratik Mukherjee,
Alex B. Valadka,
Wayne A. Gordon,
David O. Okonkwo,
Peter Davies,
Sanjeev Agarwal,
Fan Lin,
George Anis Sarkis,
Hamad Yadikar,
Zhihui Yang,
Geoffrey T. Manley,
Kevin Wang,
Shelly R. Cooper,
Kristen Dams-O’Connor,
Allison J. Borrasso,
Tomoo Inoue,
Andrew I.R. Maas,
David Me,
David M. Schnyer,
Mary J. Vassar
Publication year - 2017
Publication title -
jama neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.298
H-Index - 231
eISSN - 2168-6157
pISSN - 2168-6149
DOI - 10.1001/jamaneurol.2017.0655
Subject(s) - traumatic brain injury , medicine , oncology , psychiatry
Annually in the United States, at least 3.5 million people seek medical attention for traumatic brain injury (TBI). The development of therapies for TBI is limited by the absence of diagnostic and prognostic biomarkers. Microtubule-associated protein tau is an axonal phosphoprotein. To date, the presence of the hypophosphorylated tau protein (P-tau) in plasma from patients with acute TBI and chronic TBI has not been investigated.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom